BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: González Castro N, Bjelic J, Malhotra G, Huang C, Alsaffar SH. Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies. Int J Mol Sci 2021;22:10355. [PMID: 34638696 DOI: 10.3390/ijms221910355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Anaganti N, Chattopadhyay A, Di Filippo M, Hussain MM. New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion. Curr Atheroscler Rep 2023. [PMID: 36913170 DOI: 10.1007/s11883-023-01095-1] [Reference Citation Analysis]
2 Hou X, Guo X, Zhang Y, Zhang Q. CRISPR/Cas genome editing system and its application in potato. Front Genet 2023;14:1017388. [PMID: 36861125 DOI: 10.3389/fgene.2023.1017388] [Reference Citation Analysis]
3 Sun W, Jiang Z, Jiang W, Yang R. Universal chimeric antigen receptor T cell therapy - The future of cell therapy: A review providing clinical evidence. Cancer Treat Res Commun 2022;33:100638. [PMID: 36184307 DOI: 10.1016/j.ctarc.2022.100638] [Reference Citation Analysis]
4 Mariot V, Dumonceaux J. Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy. Front Genome Ed 2022;4. [DOI: 10.3389/fgeed.2022.937879] [Reference Citation Analysis]
5 Talluri S. Engineering and Design of Programmable Genome Editors. J Phys Chem B 2022. [PMID: 35819243 DOI: 10.1021/acs.jpcb.2c03761] [Reference Citation Analysis]
6 Rahman MU, Bilal M, Shah JA, Kaushik A, Teissedre PL, Kujawska M. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease. Pharmaceutics 2022;14:1252. [PMID: 35745824 DOI: 10.3390/pharmaceutics14061252] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Song Y, Zheng Z, Lian J. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Front Cardiovasc Med 2022;9:889519. [DOI: 10.3389/fcvm.2022.889519] [Reference Citation Analysis]
8 Hou Y, Zhang X, Sun X, Qin Q, Chen D, Jia M, Chen Y. Genetically modified rabbit models for cardiovascular medicine. Eur J Pharmacol 2022;:174890. [PMID: 35300995 DOI: 10.1016/j.ejphar.2022.174890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]